Successful treatment of Staphylococcus haemolyticus endocarditis in extremely premature baby with daptomycin

Suzan Suhail Asfour, Fahad Aljobair, Ibrahim Hammami, Adli Abdelrahim, Mountasser M. Al-Mouqdad

Abstract


Daptomycin is a novel lipopeptide antibiotic with rapid activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. We are reporting the first case of successfully using daptomycin to treat infective endocarditis in an extremely premature baby.

Keywords


endocarditis; daptomycin; neonate; premature; Staphylococcus haemolyticus; sepsis

Full Text: PDF Number of abstract views: 156 Number of PDF views/downloads: 80

 

N.B. All JPNIM articles are accessible in Open Access. You can access the page containing the full PDF article just by clicking on the “Full Text: PDF” link at the bottom of the abstract page. On the full article page, if the article doesn’t load properly in the PDF view window, please wait a few seconds or click on the “Download this PDF file” link.

Technical advice. If you are using Firefox and you are experiencing problems, please set the browser preferences as follows: Firefox > Preferences > Advanced > General > Accessibility > deselect "Warn me when web sites try to redirect or reload the page".

Privacy Policy. English text: Privacy Policy; Italian text: Privacy Policy.

Cookie Policy. English text: Cookie Policy; Italian text: Cookie Policy.